Neuland Labs

Neuland to open commercial peptide facility as part of planned phased expansion

The CDMO’s Module 1 commercial production facility to be operational by summer 2026 9 March 2026 -- Hyderabad, India -- Neuland Laboratories  will open its new commercial peptide facility in the summer of 2026 at its 17-acre Bonthapally manufacturing campus, with further capacity expansions planned as client demand increases. The first of four planned modules is expected...
11th Floor (5th Level), Phoenix IVY Building, Plot No. 573A-III, Road No. 82, Jubilee Hills, Hyderabad, 500033, Telangana, India.

+91 40 67611600 / 700